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The integrity of the visual system is highly de-
pendent  on  functional  retinal  ganglion  cells 
(RGCs). Neuronal death after initial retinal   
insult leads to a vicious cycle of neurotoxicity 
that results in spread of damage. The evoked 
mechanisms of protection and repair are appar-
ently insufficient, resulting in further death of 
RGCs. The death of these cells is common to 
many retinal neuropathies and is a major cause 
of blindness worldwide.
Cell renewal, a common healing process 
in peripheral tissues, is limited in the adult 
neural retina (Moshiri et al., 2004; Reh and 
Fischer, 2006). However, a quiescent popu-
lation of retinal progenitor cells (RPCs) con-
tinues to exist in the retinal ciliary body (CB) 
throughout adulthood and has the potential 
to differentiate into various cells of the retina 
(Ahmad et al., 2000; Tropepe et al., 2000) or 
to possibly serve as a source of immunomod-
ulatory or neurotrophic agents (Martino and 
Pluchino, 2006; Gamm et al., 2007; Einstein 
and  Ben-Hur,  2008;  Stanke  and  Fischer, 
2010).  This  dormant  progenitor  cell  niche 
was  reported  to  be  stimulated  after  retinal   
injury (Nickerson et al., 2007; Wohl et al., 
2009), although the underlying mechanisms 
are yet to be revealed. Unraveling the heal-
ing processes that operate in response to in-
jury and finding ways to enhance them could 
lead to the development of new therapies for 
promoting neuroprotection and cell renewal, 
which  is  among  the  research  goals  in  this 
field (Levin, 2003; Weinreb, 2007; Howell 
et al., 2008).
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The death of retinal ganglion cells (RGCs) is a hallmark of many retinal neuropathies. Neuro-
protection, axonal regeneration, and cell renewal are vital for the integrity of the visual system 
after insult but are scarce in the adult mammalian retina. We hypothesized that monocyte-
derived macrophages, known to promote healing in peripheral tissues, are required after an 
insult to the visual system, where their role has been largely overlooked. We found that after 
glutamate eye intoxication, monocyte-derived macrophages infiltrated the damaged retina of 
mice. Inhibition of this infiltration resulted in reduced survival of RGCs and diminished  
numbers of proliferating retinal progenitor cells (RPCs) in the ciliary body. Enhancement  
of the circulating monocyte pool led to increased RGC survival and RPC renewal. The infiltrat-
ing monocyte-derived macrophages skewed the milieu of the injured retina toward an anti-
inflammatory and neuroprotective one and down-regulated accumulation of other immune  
cells, thereby resolving local inflammation. The beneficial effect on RGC survival depended  
on expression of interleukin 10 and major histocompatibility complex class II molecules by 
monocyte-derived macrophages. Thus, we attribute to infiltrating monocyte-derived  
macrophages a novel role in neuroprotection and progenitor cell renewal in the injured  
retina, with far-reaching potential implications to retinal neuropathies and other  
neurodegenerative disorders.
© 2011 London et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months it 
is available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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Figure 1.  Recruitment and activation of innate immune cells after insult to the inner retina. RGCs were quantified in noninjured and injured 
retinas 7 d after glutamate intoxication (a–d). (a and b) Brn3a+ RGCs, red (bar, 500 µm). Insets show higher magnification (bar, 100 µm). Arrows indicate 
Brn3a+ cells. n = 3 per group. Data shown are representative of three independent experiments. (c and d) Retrogradely Fluoro-Gold–labeled RGCs, blue 
(bar, 50 µm). n = 3–4 per group. Data shown are representative of five independent experiments. (e and f) Immunohistochemical analysis of noninjured 
and injured retinal sections from Cx3cr1GFP/+ mice. CX3CR1, red; myeloid activation marker IB-4, green; Hoechst, blue (bar, 200 µm). Insets show higher 
magnification of representative CX3CR1-GFP+ myeloid cells (bar, 100 µm). Bar graphs show quantification of CX3CR1-GFP+IB4+ myeloid cells in noninjured 
and injured retinas. n = 3 per group. (g and h) Immunohistochemical analysis of noninjured and injured retinal sections from CD11cGFP/+ mice. CD11c-GFP, 
red; IB-4, green (bar, 200 µm). Arrows indicate double-labeled cells. Bar graphs show quantification of CD11c+IB-4+ cells in noninjured and injured retinas. 
n = 3 per group. Data shown are representative of two independent experiments. (i) Confocal imaging of noninjured and injured flat-mount retinas from 
Cx3cr1GFP/+ mice (bar, 100 µm). Insets show higher magnification of representative cells (bar, 10 µm). ONL, outer nuclear layer; OPL, outer plexiform layer; 
INL, inner nuclear layer. Bar graphs throughout figure show mean ± SE of each group. *, P < 0.05; **, P < 0.01; ***, P < 0.001.JEM VOL. 208, January 17, 2011 
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Outside the central nervous system (CNS), healing pro-
cesses require the help of the immune system for clearance 
of dead cells and cell debris and for support of regrowth and 
cell renewal. These processes are mediated, in part, by differ-
ent subsets of macrophages that acquire discrete phenotypes 
over the time course of healing. In the course of a response 
to any insult, there is a pivotal stage of termination of the 
local immune response involving monocyte-derived macro-
phages, which contribute to an overall antiinflammatory 
milieu and produce growth factors needed for regeneration 
(Gordon and Taylor, 2005; Arnold et al., 2007; Nahrendorf 
et al., 2007; Weber et al., 2007; Mosser and Edwards, 2008; 
Geissmann et al., 2010).
The need for neuroprotective agents after injury, to-
gether with the beneficial roles of monocyte-derived macro-
phages in tissue repair in the periphery (Arnold et al., 2007; 
Nahrendorf et al., 2007; Mosser and Edwards, 2008) and 
after spinal cord injury (Shechter et al., 2009), has led us to 
our current hypothesis that infiltrating monocyte-derived 
macrophages are required for healing of the inner retina   
after insult.
In the present study, we demonstrated that retinal insult 
in mice, inflicted in models of glutamate intoxication and   
elevated intraocular pressure (IOP), evokes vast changes in 
morphology and activation of innate immune cells. Using 
BM chimeras, we showed that monocyte-derived macro-
phages infiltrate the retina only after the insult and localize to 
the injured ganglion cell layer (GCL). We further discovered 
that these macrophages support RGC survival and progenitor 
cell renewal through their ability to skew the retinal milieu 
toward an antiinflammatory and neurotrophic one. The ben-
eficial effect of these cells on RGC survival was found to be 
dependent on their expression of the antiinflammatory cyto-
kine IL-10 and of MHC-II molecules.
RESULTS
Characterization of myeloid immune cells after RGC insult
To understand the involvement of myeloid immune cells 
(resident and infiltrating) in the dynamic events occurring 
after retinal insult, we first studied this population in the 
adult  retina  under  physiological  and  pathological  condi-
tions. We chose to use a model of retinal intoxication with 
glutamate (Schori et al., 2002; Schwartz and Kipnis, 2007), 
a  common  mediator  of  toxicity  under  neurodegenera-
tive conditions (Dreyer et al., 1996; Shaw and Ince, 1997; 
Yoles and Schwartz, 1998; Dirnagl et al., 1999; Vorwerk 
et  al.,  1999;  Gupta  and  Yücel,  2007).  Surviving  RGCs 
were assessed in this study 7 d after glutamate intoxica-
tion by immunostaining for Brn3a, a specific RGC marker   
(Nadal-Nicolás et al., 2009; Fig. 1, a and b), and by retro-
grade labeling of RGCs with Fluoro-Gold (Fig. 1, c and d),   
a commonly used method which labels the cell bodies of 
anatomically  intact  axons  (Schori  et  al.,  2002;  Schwartz 
and Kipnis, 2007). Cx3cr1GFP/+ transgenic mice that carry 
a GFP reporter under the CX3CR1 promoter (Jung et al., 
2000) were used to detect CX3CR1+ cells of the mono-
nuclear  myeloid  lineage,  regardless  of  their  origin  (resi-
dent or infiltrating). CX3CR1-GFP+ cells were seen both 
in the naive and intoxicated retinas (Fig. 1 e). Yet, gluta-
mate intoxication resulted in higher numbers of activated 
Figure 2.  Appearance of a distinct  
innate immune cell population after  
insult in models of glutamate intoxica-
tion and elevated IOP. Flow cytometric 
analysis of noninjured and injured retinas 
from Cx3cr1GFP/+ mice for Ly6C and CX3CR1-
GFP expression on CD11b+ myeloid cells. 
Cells in dot plots to the right are gated on 
the CD11b+CX3CR1-GFP+ population (a–d). 
(a) Note the appearance of the CX3CR1- 
GFPintLy6C+ population exclusively in the 
injured retina. (b) Relative contribution of 
distinct innate immune populations at dif-
ferent time points after glutamate intoxica-
tion. n = 3 per group. Bar graphs show  
mean ± SE of each group. Data shown are rep-
resentative of two independent experiments. 
Asterisks above bars indicate significant dif-
ferences compared with noninjured retina; 
significant differences between different 
time points are indicated by asterisks  
between bars. (c and d) Flow cytometric 
analysis in the elevated IOP model  
(pooled data of three animals per group  
per time point). *, P < 0.05; **, P < 0.01;  
***, P < 0.001.26 Retinal neuroprotection and repair by monocytes | London et al.
phological  differences  among  these  innate  immune  cells 
under normal versus pathological conditions. In the naive 
retina, the CX3CR1-GFP+ cells had a ramified configu-
ration with extensive processes (Fig. 1 i), a morphology 
reminiscent of resident/resting microglia (Nimmerjahn et al.,   
2005). In the injured retina, some of the cells had an ameboid- 
like shape with smaller processes (Fig. 1 i), indicating activation   
IB-4+CX3CR1-GFP+ myeloid cells, which are mainly lo-
cated in the proximity of the RGCs (GCL and inner plexi-
form layer [IPL]; Fig. 1, e and f). Additionally, quantitative 
analysis showed higher numbers of activated myeloid cells 
(IB-4+) expressing CD11c in the intoxicated retina (Fig. 1, 
g and h) of CD11cGFP/+ transgenic mice (Jung et al., 2002). 
Confocal imaging of whole-mount retinas revealed mor-
Figure 3.  Monocyte-derived macrophages infiltrate the retina after injury. [Cx3cr1GFP/+ > WT] BM chimeric mice were generated and subjected to gluta-
mate intoxication, as described in Materials and methods, and their retinas were analyzed for the presence of infiltrating monocyte-derived macrophages (a–g). 
(a) Immunohistochemical analysis of retinal sections for activated infiltrating monocyte-derived macrophages. CX3CR1-GFP, red; IB-4, green (bar, 50 µm).  
Arrows indicate double-labeled cells. (b) Live imaging of noninjured and injured retinas. Blood vessels were labeled with dextran rhodamine, red. Insets show flat 
mounts of live-imaged retinas (bar, 50 µm). (c and d) Representative dot plots and their quantitative analysis showing the kinetics of monocyte-derived macro-
phage infiltration (CD11b+CX3CR1-GFP+) after the insult. (e and f) Changes in CX3CR1-GFP mean fluorescence intensity of the infiltrating monocyte-derived 
macrophages at different time points after injury. c–f: n = 3 per group, per time point. Data shown are representative of two independent experiments. Asterisks 
above bars indicate significant differences compared with noninjured retina. Significant differences between time points are indicated by asterisks between bars. 
(g) Expression of distinct markers by the infiltrating monocyte-derived macrophages in the injured retina. Bars demarcate cells positive for the indicated marker 
(isotype control, gray). Numbers above bars refer to percentage of cells positive for the indicated marker out of the CD11b+CX3CR1-GFP+ gated population, rep-
resenting infiltrating monocyte-derived macrophages. A total of six retinas were pooled and tested for the relevant markers. Data shown are representative of 
two to three independent experiments. Bar graphs throughout figure show mean ± SE of each group. *, P < 0.05; **, P < 0.01; ***, P < 0.001.JEM VOL. 208, January 17, 2011 
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intoxication, a discrete population of CD11b+CX3CR1-GF-
PintLy6C+ cells was detected (Fig. 2, a and b). To test whether 
the observed changes in the myeloid immune populations were 
related to the type of insult or, rather, reflected a general phe-
nomenon evoked by damage to the inner retina, we used an-
other model of retinal insult that also leads to degeneration of 
of the existing cells and/or recruitment of an additional 
myeloid population.
Next, we quantified distinct innate immune populations in 
naive and injured retinas. Flow cytometric analysis indicated the 
existence of a CD11b+CX3CR1-GFPhighLy6C population in 
the naive noninjured retina (Fig. 2, a and b). After glutamate 
Figure 4.  Monocyte-derived macrophages 
are essential for RGC survival. Glutamate-
intoxicated mice were administered the MC-21 
antibody and their eyes were analyzed for RGC 
survival (a–f). (a) Flow cytometric analysis  
showing the selective depletion of 
CD115+CD11b+Ly6C+ monocytes in the blood. 
Numbers indicate the percentage of 
CD11b+Ly6C+ monocytes out of the total 
CD115+CD11b+ monocyte population. n = 5 per 
group. Data shown are representative of  
six independent experiments. (b) Recruitment  
of monocyte-derived macrophages 
(CD11b+CX3CR1-GFP+) to the injured retinas of 
[Cx3cr1GFP/+ > WT] BM chimeric mice with and 
without MC-21 treatment. n = 3 per group. Data 
shown are representative of two independent 
experiments. (c and d) Representative micro-
graphs of retinas stained for the RGC marker 
Brn3a (red; bar, 500 µm), and respective quanti-
fication of RGC loss in MC-21–treated and un-
treated injured retinas. n = 5–8 per group. Data 
are presented as percentage of RGC loss relative 
to noninjured retina. Insets show higher magni-
fication of representative Brn3a+ RGCs (bar,  
100 µm). Arrows indicate Brn3a+ cells. (e and f) 
Representative micrographs of RGCs in MC-21-
treated and untreated injured retinas stereotac-
tically labeled with Fluoro-Gold (blue; bar, 50 
µm) and quantification of RGC loss. n = 4–6  
per group. Data are presented as percentage of 
RGC loss relative to noninjured retina.  
(g–m) Injured mice were adoptively transferred 
with CD115+ monocytes (WT or Cx3Cr1GFP/+) 1 d 
after injury, and their eyes were analyzed for 
RGC survival. Flow cytometric analysis showing 
the Cx3Cr1GFP/+ donor cells (g) and their presence 
in the blood of recipient mice (h; cells in dot  
plot to the right are gated on CD11b+CD115+ 
population). (i) Flow cytometric analysis of adop-
tively transferred cells (CD11b+CX3CR1-GFP+) in 
noninjured retinas, and in retinas excised 36 h 
and 3 d after injury. h and i: n = 3 per group, per 
time point. (j and k) Representative micrographs 
of retinas from injured mice with and without 
monocyte transfer, stained for the RGC marker 
Brn3a (red; bar, 500 µm) and respective quantifi-
cation. n = 4 per group, Data are presented as 
percentage of RGC loss relative to noninjured 
retina. Insets show higher magnification of 
representative Brn3a+ RGCs (bar, 100 µm).  
Arrows indicate Brn3a+ cells. (l and m) Representative micrographs of RGCs in retinas from injured mice with and without monocyte transfer, stereotactically 
labeled with Fluoro-Gold (blue; bar, 50 µm), and quantification of RGC loss. n = 4 per group. Data are presented as percentage of RGC loss relative to noninjured 
retina. Data shown are representative of two independent experiments. Bar graphs throughout figure show mean ± SE of each group. *, P < 0.05; **, P < 0.01.28 Retinal neuroprotection and repair by monocytes | London et al.
Figure 5.  Monocyte-derived macrophages contribute to the neuroprotective and antiinflammatory retinal milieu. (a) Changes in mRNA tran-
script levels of a series of cytokines in injured compared with noninjured retinas, as a function of time after the insult. (b) Changes in the mRNA tran-
script levels of various cytokines after MC-21 treatment, compared with injured untreated (left) and noninjured (right) retina. (c) Changes in mRNA levels 
of additional factors in the injured retina at day 2 after injury, with and without MC-21 treatment, presented relative to noninjured retina. (d) Changes in JEM VOL. 208, January 17, 2011 
Article
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RGCs: elevated IOP (Da and Verkman, 2004; Ben Simon   
et al., 2006). In this model, similar immune changes were ob-
served (Fig. 2, c and d). Collectively, these results demonstrated 
the appearance of a distinct myeloid cell population after retinal 
insult and prompted us to consider the possibility that these cells 
are infiltrating monocyte-derived macrophages.
Infiltrating monocyte-derived macrophages are recruited  
to the damaged retina
To address the possibility that myeloid cells infiltrate from the 
blood to the injured retina, we used [Cx3cr1GFP/+ > WT] BM 
chimeras, whose WT BM had been replaced with that of   
Cx3cr1GFP/+ mice. In the resulting recipient mice, only infil-
trating monocytes were labeled because they derive from   
donor BM, as opposed to resident microglia which exist in the 
retina from early ontogeny. This procedure enabled infiltrating 
monocyte-derived macrophages to be distinguished from resi-
dent microglia (Rolls et al., 2008; Shechter et al., 2009). Nota-
bly, the heads of the chimeric mice were shielded during the 
irradiation process, which protected their eyes and brains from 
any damage other than that induced by glutamate intoxication. 
In the absence of retinal intoxication, no infiltration of GFP+ 
cells to the retina could be seen in these chimeras by both   
immunohistochemical analysis and live in vivo imaging (Fig. 3, 
a and b), confirming that in the healthy retina there is hardly 
any turnover of microglia. In glutamate-intoxicated retinas, an 
infiltration of activated monocyte-derived macrophages was 
observed at day 2 after injury (Fig. 3, a and b). Importantly, 
most of the infiltrating cells (77.5 ± 1.9%; mean ± SE) were 
recruited to the area of lost RGCs, namely the GCL and IPL. 
Using flow cytometry, we followed the kinetics of infiltration 
of these cells into the damaged retina. Infiltrating cells were 
first detected 12 h after injury and peaked at day 2 (Fig. 3,   
c and d). Notably, at the early stage after injury, the majority of 
infiltrating cells expressed intermediate levels of the CX3CR1 
receptor, whereas later on most of the cells were CX3CR1-
GFPhigh (Fig. 3, e and f). In contralateral eyes, which served as 
control, no infiltrating cells were observed (unpublished data), 
suggesting the existence of specific recruitment signals in the 
injured retina. In addition, we evaluated the characteristics and 
state of activation of the infiltrating CD11b+CX3CR1-GFP+ 
cells 2 d after injury. Infiltrating cells were found to express 
Ly6C, F4/80, CD11c, and MHC-II (Fig. 3 g).
Monocyte-derived macrophages promote survival of RGCs 
after retinal insult
To  study  the  involvement  of  monocyte-derived  macro-
phages  in  RGC  survival,  we  used  the  anti-CCR2  anti-
body MC-21 (Mack et al., 2001), which selectively depletes 
CD115+CD11b+Ly6C+ monocytes from the blood (Fig. 4 a).   
The  ablation  of  circulating  Ly6C+  monocytes  resulted  in 
decreased  recruitment  of  monocyte-derived  macrophages 
(CD11b+CX3CR1-GFP+) to the injured retina, as assessed 
in  retinas  of  [Cx3cr1GFP/+  >  WT]  BM  chimeras  at  day  2   
after injury (Fig. 4 b). Ablation of the Ly6C+ monocyte pool 
resulted in higher RGC loss 7 d after the insult, as indicated 
by quantitative analysis of Brn3a+ cells in the GCL (Fig. 4, 
c and d). These results were further confirmed by analysis 
of retrogradely Fluoro-Gold–labeled cells in whole-mount 
glutamate-intoxicated retinas (Fig. 4, e and f).
We next tested whether boosting monocyte levels in the 
blood would lead to enhanced survival of RGCs. To this   
end, we adoptively transferred 4–5 × 106 labeled monocytes 
(Cx3cr1GFP/+) into the blood of congenic injured mice, 1 d   
after injury (Fig. 4, g and h). Flow cytometric analysis indi-
cated that these monocytes could not be detected in the non-
injured contralateral retina but were observed in the injured 
retina at day 3 after the injury (Fig. 4 i). Quantitative analysis 
of Brn3a+ cells demonstrated higher survival of RGCs 7 d   
after the injury in mice that were adoptively transferred i.v. 
with naive monocytes (Fig. 4, j and k). This increased survival 
was further confirmed by quantifying the number of anatomi-
cally intact surviving RGCs using Fluoro-Gold labeling (Fig. 4, 
l and m). Together, these results demonstrated the neuropro-
tective role of infiltrating monocyte-derived macrophages in 
rescuing RGCs after insult. They encouraged us to explore 
the contribution of monocyte-derived macrophages to the 
retinal molecular and cellular milieu after injury.
Monocyte-derived macrophages contribute  
to the neuroprotective and antiinflammatory  
local milieu of the retina after injury
To evaluate the effect of monocyte-derived macrophages on 
the local milieu after insult, we analyzed the immunological 
profile of the retina by quantitative real-time PCR. Within the 
first 6 h, an elevation in the mRNA transcript levels of the pro-
inflammatory cytokines il-6 and il-12-p35, as compared with 
mRNA transcript levels of cntf at day 2 after injury, after MC-21 treatment, presented relative to noninjured retina. In a–d, a fold change of 1 indicates no 
change relative to the relevant control. The numbers situated above 1 indicate a fold increase, whereas the numbers below 1 indicate a fold decrease 
(values presented on a logarithmic scale). For all experiments, n = 3–6 per group, per time point. Data shown are representative of one to two indepen-
dent experiments. Asterisks above bars represent statistical significance compared with the relevant control. In c and d, asterisks between bars represent 
statistical significance with respect to the MC-21 treatment. (e) Representative micrographs of retinas from day 2 after injury, showing the expression of 
TGF- (red, left) and IL-10 (red, right) by activated IB-4+ myeloid cells (green; bar, 50 µm). Insets show higher magnification of representative double-
labeled cells (bar, 5 µm). (f) Representative micrographs of retinas from [Cx3cr1GFP/+ > WT] BM chimeras on day 2 after injury, showing the expression of 
TGF- (red, left) and IL-10 (red, right) by infiltrating GFP+ monocyte-derived macrophages (green; bar, 50 µm). Insets show higher magnification of repre-
sentative double-labeled cells (bar, 5 µm). (g and h) Representative micrographs of Fluoro-Gold–labeled retinas (blue; bar, 50 µm) from noninjured and 
injured mice without monocyte transfer and from injured mice adoptively transferred with WT, IL-10–deficient, or MHC-II–deficient monocytes. Bar graph 
shows quantification of RGC loss in the various groups. n = 4–6 per group. Data are presented as percentage of RGC loss relative to noninjured retina. 
Bar graphs throughout figure show mean ± SE of each group. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Figure 6.  Monocyte-derived macrophages regulate the accumulation of other immune cells in the injured retina. (a–d) Representative micro-
graphs showing activated IB-4+ cells (green; bars, 500 µm) in injured retinas at days 4 and 7 after injury from mice treated with MC-21 compared with 
untreated injured mice, and respective quantification. n = 3–5 per group. Insets show higher magnification (bars, 50 µm). Arrows indicate GCL. (e) Quanti-
tative analysis showing the kinetics of neutrophil (CD11b+CX3CR1-GFP) accumulation after insult in Cx3cr1GFP/+ transgenic mice. n = 2–3 per time point. 
Asterisks above bars indicate significant differences compared with noninjured retina. Significant differences between time points are indicated by  
asterisks between bars. (f and g) Flow cytometric analysis and respective quantification, showing the effect of monocyte depletion on neutrophil 
(CD11b+CX3CR1-GFP) accumulation after insult. n = 3–5 per group. Data shown are representative of two independent experiments. (h) Representative 
histogram demonstrating the expression of the Ly6G granulocytic marker by CD11b+CX3CR1-GFP neutrophils in the injured retina. Bar graphs through-
out figure show mean ± SE of each group. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
noninjured retina, was observed (Fig. 5 a). This increase was 
accompanied by elevated transcript levels of tgf-1 and tgf-2 
(Fig. 5 a), which are commonly considered antiinflammatory 
cytokines but in the context of IL-6 are able to drive a Th17-
mediated  proinflammatory  response  (Bettelli  et  al.,  2006;   
Mangan et al., 2006; Veldhoen et al., 2006). Thus, at this early 
time point, before monocyte-derived macrophages could be 
observed in the retina (Fig. 3, c and d), the overall profile was 
proinflammatory. We further analyzed IL-6 and TGF-1 at 
this time point by ELISA and found a similar trend (85.13 ± 
13.90 pg/mg protein vs. 35.78 ± 2.61 for IL-6 and 10.37 ± 
3.06 pg/mg protein vs. 4.27 ± 1.30 for TGF-1, in injured vs. 
noninjured retinas, respectively; mean ± SE). TGF- expres-
sion was also demonstrated by immunohistochemical staining JEM VOL. 208, January 17, 2011 
Article
31
macrophages also affected local expression of neurotrophic 
factors. We focused on ciliary neurotrophic factor (CNTF), 
an axogenesis factor for RGCs, which promotes their sur-
vival (Jo et al., 1999; Pease et al., 2009). Before monocyte 
recruitment, namely, at 6 h after injury, mRNA levels of this 
factor were not changed compared with noninjured retinas 
(Fig. S2 a). However, at day 2 after the insult, a significant 
increase was observed, which was attenuated by the deple-
tion of monocytes (Fig. 5 d). These results, together with the 
findings that adoptive transfer of monocytes did not affect cntf 
levels, as tested at day 7 (Fig. S2 b), suggest that increased cntf 
expression in the injured retina is a monocyte-dependent 
event that occurs early after their infiltration.
We  considered  the  possibility  that  the  contribution  of 
monocyte-derived macrophages to the restoration of homeosta-
sis is dependent on antiinflammatory cytokines and, therefore, 
explored the cellular sources of these cytokines. Immunohisto-
chemical analysis of injured retinas from day 2 revealed the ex-
pression of TGF- and IL-10 by activated myeloid cells (IB-4+; 
Fig. 5 e). By staining sections from [Cx3cr1GFP/+ > WT] BM 
chimeras, we discovered that these cytokines were expressed by 
infiltrating monocyte-derived macrophages located at the GCL 
and IPL (Fig. 5 f). It should be noted that additional cells, other 
than the monocyte-derived macrophages, appeared to express 
these cytokines as well.
To examine whether the monocyte-dependent changes 
in the local milieu are part of the mechanisms by which these 
cells promote RGC survival, we focused on IL-10, a hall-
mark of healing antiinflammatory macrophages which is 
known for its immunosuppressive functions (Moore et al., 
2001; Werner and Grose, 2003). To this end, we adoptively 
transferred injured mice with monocytes from IL-10–deficient 
donors. Fluoro-Gold labeling indicated that the transferred 
IL-10–deficient monocytes failed to protect RGCs as com-
pared with WT monocytes, resulting in loss of RGCs similar 
to that in mice that did not receive monocyte supplementa-
tion (Fig. 5, g and h). These results suggest that infiltrating 
monocyte-derived macrophages contributed to RGC sur-
vival by acquiring an antiinflammatory phenotype. In addi-
tion,  passive  transfer  of  MHC-II–deficient  monocytes, 
similarly to the IL-10–deficient monocytes, failed to contrib-
ute to neuronal survival (Fig. 5, g and h).
Monocyte-derived macrophages regulate the accumulation 
of other immune cells in the injured retina
To further decipher the mechanisms by which monocyte-
derived macrophages promote neuroprotection, we turned 
to investigate how these cells, and the immunoregulatory   
milieu they promote, affect other immune cells in the retina. 
Specifically, we tested for immune cells whose unregulated 
accumulation is known to result in spread of damage after 
CNS insults, such as activated microglia and neutrophils   
(Andrews et al., 1999; Liu and Hong, 2003; Gronert, 2010). 
Retinas were collected at day 4 after injury from mice with 
and without monocyte depletion by systemic administration 
of the MC-21 antibody. Depletion of monocytes resulted in 
on IB-4+ cells (Fig. S1). By day 2 after injury, the time point   
of  peak  monocyte-derived  macrophage  infiltration  (Fig.  3,   
c and d), the immunological profile had shifted toward an anti-
inflammatory one. This shift was manifested by down-regula-
tion in the mRNA levels of the proinflammatory cytokines il-6 
and il-12-p35, along with an up-regulation of the antiinflam-
matory cytokines tgf-1 and tgf-2, as compared with non-
injured retinas (Fig. 5 a). A trend toward the resolution of the 
immunological response was first observed at day 4 after injury 
and continued through day 7, at which mRNA levels of most 
of these cytokines, with the exception of tgf-1, were compa-
rable to those in noninjured contralateral retinas (Fig. 5 a). 
These changes in the immunological milieu of the injured ret-
ina, which correlated with the absence or presence of infiltrat-
ing monocyte-derived macrophages at 6 h and 2 d after injury, 
respectively,  indicated  a  possible  role  of  monocyte-derived 
macrophages in skewing the local milieu toward an antiinflam-
matory one.
To further establish the role of monocyte-derived macro-
phages in regulating the immunological milieu, we made use 
of the MC-21 antibody to deplete the monocyte population in 
the blood, thereby enabling us to observe the local retinal en-
vironment after injury, in the absence of monocyte recruit-
ment. As opposed to the antiinflammatory shift at day 2 after 
injury (Fig. 5 a), quantitative real-time PCR analysis of retinas 
from MC-21–treated mice, excised at the same time point, 
demonstrated a characteristic proinflammatory profile. Namely, 
mRNA levels of the antiinflammatory cytokines tgf-1 and 
tgf-2 were down-regulated, whereas the levels of proinflam-
matory cytokines were robustly increased, compared with in-
jured mice which had not been treated with MC-21 (Fig. 5 b, 
left). Importantly, the mRNA levels of il-6, il-12-p35, and   
tgf-1  in  retinas  from  MC-21–treated  mice  were  elevated 
compared with noninjured retinas (Fig. 5 b, right), indicating 
that in the absence of infiltrating monocyte-derived macro-
phages the proinflammatory environment was not resolved.
To  substantiate  the  contribution  of  monocyte-derived 
macrophages to the antiinflammatory milieu, the presence of 
additional immune components was examined at day 2 after 
injury. An increase in mRNA levels of the antiinflammatory 
mediators il-10, il-4, and arg-1 was observed. Monocyte de-
pletion prevented the increase in il-10 and il-4 transcript lev-
els and attenuated the elevation in arg-1 (Fig. 5 c), confirming 
the antiinflammatory influence of these cells. The monocyte-
driven effects appear to be specific for certain mediators but 
not others, as mRNA levels of tgf-3, il-27, il-1, and tnf- 
were  not  affected  by  monocyte  depletion  (not  depicted). 
Adoptive transfer of monocytes further contributed to reso-
lution of the local immune response, as was manifested by a 
decrease in tgf-1 mRNA levels relative to injured retinas 
from mice that did not receive monocyte transfer (1.5 ± 0.1-
fold decrease at day 4, P < 0.01, and 2.3 ± 0.3 at day 7 after 
injury, P = 0.06), resulting in levels closer to those of naive 
noninjured retinas.
The observed effects of monocyte-derived macrophages 
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Figure 7.  Activation of the quiescent progenitor niche in the adult CB after insult. (a) mRNA levels of egfr in noninjured and injured retina.  
n = 3–5 per group. Data shown are representative of two independent experiments. (b and c) Injured and noninjured mice were subjected to a BrdU regi-
men to label proliferating cells. (b) Quantification of proliferating RPCs (BrdU+Pax6+) in the glutamate intoxication (GT) and elevated IOP models. n = 4–6 
per group. Data shown are representative of one (elevated IOP) or two (GT) independent experiments. (c) Representative micrographs of CBs of control 
(top), glutamate-intoxicated (middle), and elevated IOP (bottom) eyes stained for the cell proliferation marker BrdU (red) and the neural/retinal progenitor 
marker Pax6 (green; bars, 200 µm in the left column and 100 µm in the other columns). Arrows indicate double-labeled cells. Insets show higher magnifi-
cation of representative proliferating RPCs (bar, 10 µm). Bar graphs throughout the figure show mean ± SE of each group. * P < 0.05, *** P < 0.001.
increased accumulation of IB-4+ cells (Fig. 6, a and b), as 
compared with injured animals that were not subjected to 
depletion. At day 7 after injury, results were similar, with a 
more pronounced effect (Fig. 6, c and d).
With respect to neutrophils, we first used flow cytometry 
to follow the kinetics of CD11b+CX3CR1 neutrophils to in-
jured retinas of Cx3cr1GFP/+ transgenic mice. These cells were 
absent from the noninjured retina and peaked at day 2 after   JEM VOL. 208, January 17, 2011 
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Figure 8.  Monocyte-derived macrophages 
contribute to RPC renewal in the CB of 
injured adult retina. (a–d) Glutamate-intoxi-
cated mice were either treated with the MC-21 
antibody or adoptively transferred with CD115+ 
monocytes, and their eyes were analyzed for 
progenitor cell renewal by staining for the  
cell proliferation marker BrdU (red) and the 
neural/retinal progenitor marker Pax6 (green). 
(a and b) Representative micrographs and re-
spective quantification of BrdU+Pax6+ cells in 
CBs of injured mice with and without MC-21 
treatment (bars, 100 µm). n = 5–6 per group. 
Data shown are representative of two indepen-
dent experiments. (c and d) Representative 
micrographs and respective quantification of 
BrdU+Pax6+ cells in CBs of adoptively trans-
ferred and untreated injured mice (bar, 100 µm). 
n = 3 per group. Throughout the figure, arrows 
indicate double-labeled cells; insets show 
higher magnification of representative prolifer-
ating RPCs (bar, 10 µm); and bar graphs show 
mean ± SE of each group. *, P < 0.05.
injury  (Fig.  6  e).  MC-21–mediated  monocyte  depletion   
resulted in elevated numbers of CD11b+CX3CR1 neutro-
phils at day 2, compared with retinas from injured untreated 
mice (Fig. 6, f and g). These cells were further characterized   
by flow cytometry and shown to express the Ly6G marker 
(Fig. 6 h), which is a common feature of granulocytic neutro-
phils. Similar results were observed at day 4 after intoxication 
(not depicted).
Collectively, these results established the immunoregula-
tory capacity of monocyte-derived macrophages in restrict-
ing the accumulation of inflammatory immune cells after 
acute retinal insult, thereby contributing to restoration of im-
mune homeostasis and to neuroprotection.
Monocyte-derived macrophages support progenitor cell 
renewal after retinal insult
In light of our findings regarding the contribution of monocyte-
derived macrophages to the retinal immunoregulatory and 
neurotrophic milieu after retinal intoxication, along with the 
reported involvement of immune cells in regulating CNS 
progenitor niches (Ziv et al., 2006; Ziv and Schwartz, 2008; 
Wolf  et  al.,  2009),  we  next  tested  whether  monocyte- 
derived macrophages could enhance progenitor cell renewal 
in the adult retina after injury.
As retinal neurogenesis is generally restricted to the early 
postnatal stage (Moshiri et al., 2004; Reh and Fischer, 2006), we 
tested whether the conditions evoked after glutamate intoxica-
tion could activate the dormant progenitor niche in the adult 
CB. Quantitative real-time PCR analysis indicated that gluta-
mate intoxication resulted in higher mRNA levels of epidermal 
growth factor receptor (egfr; Fig. 7 a), which 
is intimately involved in cell renewal 
and proliferation (Anchan et al., 1991; 
Close et al., 2006; Giordano et al., 2007), suggesting that the in-
jury did, in fact, induce conditions permissive for cell renewal.
To follow RPC renewal, mice were injected intravitreally 
with the cell proliferation marker BrdU immediately after injury 
and for 3 additional consecutive days. Retinal insult resulted in 
the activation of the dormant progenitor niche; increased num-
bers of BrdU+Pax6+ neural progenitor cells could be seen in the 
CB of intoxicated eyes compared with control eyes 4 d after in-
jury (Fig. 7, b and c). The activation of quiescent progenitors 
was further verified by the elevated IOP model (Fig. 7, b and c) 
to control for any direct effect of the glutamate.
To test the contribution of recruited monocyte-derived 
macrophages to progenitor cell renewal observed after insult, 
the anti-CCR2 antibody MC-21 was used. In comparison 
with  intoxicated  untreated  retinas,  monocyte  ablation  re-
sulted in reduced numbers of BrdU+Pax6+ RPCs in the CB 
(Fig. 8, a and b), establishing the role of infiltrating monocyte-
derived macrophages in supporting cell renewal in the dam-
aged eye. To test whether augmentation of the monocytic 
pool can enhance progenitor cell renewal beyond spontane-
ous levels, we performed adoptive transfer of naive monocytes 
to the injured mice 1 d after injury. This treatment augmented 
the number of proliferating progenitor cells in the CB (Fig. 8, 
c and d), further demonstrating the contribution of monocyte-
derived  macrophages  to  the  activation  of  the  progenitor 
niche  in  the  adult  injured  eye.  Considering  that  BrdU   
was injected for 4 consecutive days, the observed changes in 
the numbers of proliferating progenitor cells may reflect a 
monocyte-mediated effect on the survival of these cells rather 
than an effect on their proliferation alone.34 Retinal neuroprotection and repair by monocytes | London et al.
myeloid-derived immunosuppressive cells (Movahedi et al., 
2008), which, in this case, take part in resolution of the in-
flammatory response. In addition to their local immunoregu-
latory contribution, monocyte-derived macrophages also 
affected the levels of neuroprotective factors such as CNTF 
and Arg-1, which can directly support neuronal survival   
(Jo et al., 1999; Pease et al., 2009; Ma et al., 2010).
Considering our current findings regarding the antiinflam-
matory nature of the infiltrating monocyte-derived macro-
phages in the injured retina, it is possible that these cells are 
part of the mechanisms that preserve ocular immune privilege. 
As an immune-privileged site, the eye uses several strategies to 
ensure a selective immune repertoire that will provide protec-
tion with minimal risk to the integrity of vision (Streilein, 
2003). One such mechanism is anterior chamber–associated 
immune deviation, a form of peripheral tolerance which de-
pends on the infiltration of circulating monocytes to the eye, 
with these cells eventually reaching the thymus and spleen. 
There, they induce regulatory T cells that can inhibit cell-
mediated immune responses (Streilein, 2003). Interestingly, 
however, ocular immune privilege may serve as a double-
edged sword, as it may result in insufficient monocyte recruit-
ment to the retina under pathological conditions. This notion 
is strengthened by our finding that increasing the monocyte 
pool promoted survival of RGCs beyond spontaneous levels. 
T cell–based vaccination was previously shown to enhance 
recruitment of monocytes to the injured spinal cord, thereby 
contributing to functional motor recovery (Shechter et al., 
2009).  It  is  thus  likely  that  the  neuroprotective  effect  of   
T cell–based vaccination, which was previously demonstrated 
in the injured retina (Fisher et al., 2001a; Schori et al., 2001; 
Schwartz, 2004; Bakalash et al., 2005; Cortes et al., 2008; Cui 
et al., 2009), is, in part, a result of enhanced recruitment of 
monocytes. This issue deserves further investigation.
The use of steroids has been suggested for therapy of vari-
ous neuropathies. However, studies in the retina have shown 
the failure of steroids to improve visual outcome after trau-
matic optic neuropathy in humans (Levin et al., 1999) or to 
rescue RGCs in various animal models (Solberg et al., 1999; 
Bakalash et al., 2003; Ohlsson et al., 2004; Dimitriu et al., 
2008). In addition, several studies have indicated that im-
mune components provide neuroprotective factors, support 
axonal regeneration after retinal injury, and mediate IOP re-
duction (Moalem et al., 1999; Schori et al., 2001; Barouch 
and Schwartz, 2002; Bakalash et al., 2003, 2005; Yin et al., 
2006; Cui et al., 2009; Alvarado et al., 2010). Those studies, 
together  with  our  identification  of  a  specific  macrophage 
population in the injured retina that is both immunoregula-
tory and neuroprotective, suggest that overall suppression of 
the immune system is not only unsuccessful in protecting 
RGCs but also eliminates the possibility of any potential   
immune-based protection.
Over the last decade, there has been hope that retinal 
neuropathies, which are resistant to current therapies, may be 
treated by administration of stem cells that will proliferate and 
differentiate to protect or replace retinal neurons. However, 
To reveal the fate of the proliferating RPCs observed   
after insult, we repeated the experiments described in the 
previous paragraph and collected the eyes 1 wk after the final 
BrdU injection, a time point suitable for assessing progenitor 
cell differentiation (Shechter et al., 2008). Immunohisto-
chemical analysis did not show colocalization of BrdU+ cells 
with any of the neuronal markers tested (unpublished data), 
namely  III-tubulin,  the  bipolar-specific  marker  PKC-, 
and the photoreceptor-specific marker recoverin, suggesting 
that the RPCs do not engage in cell replacement but can po-
tentially exert neurotrophic or immunoregulatory functions.
DISCUSSION
This  study  attributes  to  monocyte-derived  macrophages  a 
key role in neuroprotection and progenitor cell renewal after 
insult to the adult retina, mediated by their antiinflammatory 
neuroreparative contribution to the local milieu. After gluta-
mate insult, monocyte-derived macrophages infiltrated the 
damaged retina, almost exclusively to the area of the injured 
RGCs. Inhibition of this infiltration resulted in excessive loss of 
RGCs, surpassing the documented clinical threshold which is 
associated with a detectable vision deficit (Kerrigan-Baumrind 
et al., 2000; Harwerth and Quigley, 2006). Beyond the posi-
tive contribution of endogenous monocyte-derived macro-
phages, exogenous administration of monocytes resulted in 
enhanced survival of RGCs. These findings establish the in-
volvement of monocyte-derived macrophages in supporting 
survival of CNS neurons, the RGCs.
Monocyte-derived macrophages were found to be crucial 
for the retinal antiinflammatory shift that occurred 2 d after 
injury. Ablation of the endogenous monocyte pool resulted 
in reduction of transcripts encoding for the antiinflammatory 
mediators tgf-1/2, il-10, il-4, and arg-1 and an increase in 
proinflammatory ones. In addition to their role in changing 
this  milieu,  the  monocyte-derived  macrophages  regulated 
the accumulation of activated innate immune cells, thereby 
promoting restoration of immune homeostasis. These prop-
erties  suggest  that  the  infiltrating  monocyte-derived  cells 
could  be  regarded  as  inflammation-resolving  macrophages 
(Bystrom et al., 2008).
Importantly, the neuroprotective effect of monocyte- 
derived macrophages on RGC survival, which was identified in 
this study, was found to be dependent, at least in part, upon 
their potential to produce IL-10. This dependence is consis-
tent with previous studies showing that antiinflammatory cyto-
kines are supportive of neuroprotection (Boyd et al., 2003; 
Koeberle et al., 2004). This is further corroborated by studies 
showing that the presence of proinflammatory cytokines has 
a negative effect on RGC survival. For instance, IL-6 defi-
ciency has been shown to increase survival of RGCs after 
mechanical and biochemical insults, whereas the reversal of 
this neuroprotective effect could be achieved by a single IL-6 
injection (Fisher et al., 2001b). Notably, we found that adop-
tive transfer of MHC-II–deficient monocytes also failed   
to contribute to RGC survival. Thus, the phenotype of   
cells that mediate neuroprotection is reminiscent of mature JEM VOL. 208, January 17, 2011 
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(B6.FVB-Tg Itgax-DTR/GFP 57Lan/J; Jung et al., 2002) carrying a trans-
gene encoding a GFP reporter under control of the murine CD11c pro-
moter were used. Animals were supplied by the Animal Breeding Center of 
The Weizmann Institute of Science. All experiments detailed herein con-
form to the regulations formulated by the Institutional Animal Care and Use 
Committee of the Weizmann Institute of Science.
BM chimeras. [Cx3cr1GFP/+ > WT] BM chimeras were prepared by subject-
ing WT recipient mice to lethal whole-body irradiation (950 rad) while 
shielding the head, as previously described (Rolls et al., 2008; Shechter et al., 
2009). This shielding prevented a direct insult to the retina and any infiltra-
tion of myeloid cells other than that induced by glutamate intoxication. On the 
subsequent day, mice were reconstituted with 5 × 106 BM cells according to 
a previously described protocol (Shechter et al., 2009). Chimeric mice were 
subjected to glutamate intoxication 8–12 wk after BM transplantation.
Glutamate-induced toxicity. Mice were anesthetized, treated with local 
anesthesia (Localin; Dr. Fischer) applied directly to the eye, and injected in-
travitreally with a total volume of 1 µl saline containing 400 nmol l-glutamate 
(Sigma-Aldrich), as previously described (Schori et al., 2002).
Elevated IOP model. Ischemic injury was produced as previously described 
(Da and Verkman, 2004; Ben Simon et al., 2006). In brief, after anesthesia, 
IOP was elevated by introducing into the anterior chamber a micropipette, 
connected to a reservoir of isotonic salt solution (Saline). The reservoir was sit-
uated at an appropriate height, inducing pressure of 120 mm Hg for 60 min.
MC-21  administration.  MC-21  (an  antibody  to  CCR2;  Mack  et  al., 
2001) was injected intraperitoneally starting immediately after the injury and 
throughout the experimental period.
Adoptive monocyte transfer. CD115+ monocytes were isolated as previ-
ously reported (Varol et al., 2007). In brief, BM cells were harvested from 
the femora and tibiae of mice and enriched for mononuclear cells on a Ficoll 
density gradient. The CD115+ BM monocyte population was isolated 
through MACS enrichment using biotinylated anti-CD115 antibodies and 
streptavidin-coupled  magnetic  beads  (Miltenyi  Biotec),  according  to  the 
manufacturer’s protocols. After this procedure, monocytes (WT, Cx3cr1GFP/+, 
IL-10 deficient, or MHC-II deficient) were injected i.v. (4–5 × 106 cells per 
mouse) on day 1 after injury.
BrdU regimen. BrdU (Sigma-Aldrich) was dissolved in PBS and injected 
intravitreally (1 µg/eye), immediately after the insult and for 3 consecutive 
days, according to a protocol adapted from Zhao et al. (2005). Injections were 
conducted repeatedly through the same hole without additional tissue pene-
tration. Retinas exhibited morphology comparable to those that had received 
a single injection. Animals were killed 1 d after the last injection to determine 
the number of proliferating progenitors or 1 wk after the last injection to de-
tect differentiation. Control animals were administered BrdU intravitreally, 
using the same regimen, in the absence of glutamate intoxication or elevated 
IOP. Notably, although we cannot rule out a synergistic effect of the injury 
followed by repeated BrdU injections on the number of proliferating RPCs, 
because an identical protocol was applied when comparing retinas/ciliary 
bodies of animals subjected to the different monocyte manipulations, changes 
in the numbers of proliferating progenitor cells after these manipulations can 
most likely be attributed to monocyte-mediated effects.
Fluoro-Gold labeling of RGCs. For detection of anatomically intact neu-
rons, mice were injected with 1 µl 5% Fluoro-Gold (Fluorochrome) solution 
in saline on day 3 after injury to both superior colliculi at the following co-
ordinates: 2.92 mm posterior to the bregma, 0.5 mm lateral to the midline, 
and at a depth of 2 mm from the skull. After 72 h, the mice were killed, their 
eyes were enucleated, and each retina was flattened as whole mount in 4% 
paraformaldehyde (PFA) in PBS. For more details, see Schori et al. (2002) 
and Schwartz and Kipnis (2007).
most of the cell replacement therapies tested have been found 
effective only for peripheral neurons of the retina, such as 
photoreceptors (Klassen et al., 2004; MacLaren et al., 2006), 
rather than for RGCs (Johnson et al., 2009), probably be-
cause of the fact that successful replacement of RGCs is much 
more complex as the new cells must extend axons to the su-
perior colliculi of the brain. Other studies have suggested that 
these stem cells contribute to neuroprotection via immuno-
modulatory functions and supply of growth factors, rather 
than serve as a source for cell replacement (Martino and 
Pluchino, 2006; Gamm et al., 2007; Einstein and Ben-Hur, 
2008; Stanke and Fischer, 2010). Because a quiescent RPC 
population exists in the adult retina (Ahmad et al., 2000; 
Tropepe et al., 2000), an alternative approach to exogenous 
stem cell administration would be to stimulate these cells, 
thereby boosting the endogenous local stem cell pool. In the 
current study, we demonstrated the contribution of monocyte-
derived macrophages to activation of the endogenous pro-
genitor niche after injury. Interestingly, in our paradigm we 
could not identify any newly generated cells that ultimately 
integrated into the retina and expressed neuronal markers. 
We  therefore  suggest  that  these  proliferating  progenitor 
cells do not engage in cell replacement but might poten-
tially  serve  as  immunomodulators  and/or  providers  of 
growth factors.
Several studies have shown that a proinflammatory en-
vironment can damage progenitor niches (Vallières et al., 
2002; Ekdahl et al., 2003; Monje et al., 2003; Rolls et al., 
2007; Pluchino et al., 2008; Balasubramaniam et al., 2009). 
Conversely,  an  environment  that  is  antiinflammatory  and 
neurotrophic, shown here to be directed by the monocyte-
derived macrophages, is known to be supportive of cell re-
newal (Molina-Holgado et al., 2001; Battista et al., 2006; Ziv 
et al., 2006; Kiyota et al., 2010), thus presenting a possible 
mechanism by which these cells contribute to activation of 
the progenitor niche.
Our results suggest that coping with retinal injury requires 
a  regulated  immune  response  in  which  monocyte-derived 
macrophages are essential and intimate partners. Because the 
main experimental model of this study was glutamate intoxi-
cation, a phenomenon relevant to many CNS neurodegener-
ative disorders (Dreyer et al., 1996; Shaw and Ince, 1997; 
Yoles and Schwartz, 1998; Dirnagl et al., 1999; Vorwerk et al., 
1999), our findings have far-reaching implications that extend 
beyond the eye. The outcomes of this study suggest the possi-
ble therapeutic potential of these cells as unique endogenous 
neuroprotective agents in treating retinal neuropathies as well 
as other CNS pathologies that involve neuronal loss.
MATERIALS AND METHODS
Animals. Adult male (8–10 wk old) C57BL/6J mice and heterozygous mu-
tant Cx3cr1GFP/+ mice (B6.129P-Cx3cr1tm1Litt/J, in which one of the CX3CR1 
chemokine receptor alleles is replaced with a gene encoding GFP; Jung   
et  al.,  2000)  were  used.  Additionally,  C57BL/6J,  heterozygous  mutant   
Cx3cr1GFP/+ mice, MHC-II null mice (B6.129S-H2dlAb1-Ea/J), and IL-10 null 
mice (B6.129P2-Il10tm1Cgn/J; Kühn et al., 1993) were used as donors of 
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specific mRNAs was assayed using fluorescence-based quantitative real-time 
PCR with the following selected gene-specific primer pairs, designed using the 
Primer Express 3.0 software (Applied Biosystems): tgf-1 forward, 5-TACC-
ATGCCAACTTCTGTCTGGGA-3 and reverse, 5-TGTGTTGGTTG-
TAGAGGGCAAGGA-3;  tgf-2  forward,  5-AATTGCTGCCTTC-
GCCCTCTTTAC-3 and reverse, 5-TGTACAGGCTGAGGACTTTG-
GTGT-3; tgf-3 forward, 5-ATTCGACATGATCCAGGGACTGGC-3 
and reverse, 5-CTCCACTGAGGACACATTGAAACG-3; il-6 forward, 
5-TGCAAGAGACTTCCATCCAGTTG-3  and  reverse,  5-TAAG-
CCTCCGACTTGTGAAGTGGT-3; il-12-p35 forward, 5-TCACC-
CTGTTGATGGTCACG-3  and  reverse,  5-AAATGAAGCTCTGCAT-
CCTGC-3;  cntf  forward,  5-AGAGCAATCACCTCTGACCCTTCA-3  
and reverse, 5-ATCTCACTCCAGCGATCAGTGCTT-3; egfr forward,   
5-ATGCCTTAGCCATCCTGTCCAACT-3 and reverse, 5-GTTGC-
TGAATCGCACAGCACCAAT-3; and gapdh forward, 5-AATGTGT-
CCGTCGTGGATCTGA-3 and reverse, 5-GATGCCTGCTTCACCA-
CCTTCT-3.
Reactions were performed using Power SYBR Green PCR Master 
Mix (Applied Biosystems). The relative amounts of mRNA were calculated 
using the standard curve method and normalized to a reference gene found 
to be best suited for our tissue, gapdh. Each sample was run in triplicate.   
Amplification conditions were: 50°C for 2 min, 95°C for 10 min, followed 
by 40 cycles of 95°C for 15 s, and 60°C for 1 min. Target amplification was 
first detected between cycles 24 and 26, on average. Dissociation curves 
showed one species of amplicon for each primer combination.
mRNA levels of il-4 (assay ID: Mm00445260_m1), il-10 (Mm00439614_
m1), arg-1 (Mm00475988_m1), tnf (Mm00443258_m1), il-27 (Mm00461164_
m1),  and  il-1  (Mm00434228_m1)  were  determined  using  TaqMan 
Real-Time PCR, according to manufacturer’s instructions (Applied Biosys-
tems).  cDNA  templates  were  amplified  with  TaqMan  PreAmp  Master   
Mix (Applied Biosystems). Threshold cycle numbers (Ct) were determined 
with  7500  system  SDS  software  (version  1.4;  Applied  Biosystems)  and   
analyzed using the Ct method, as described by the manufacturer, using 
gapdh (Mm99999915_g1) as the calibrator gene. All quantitative real-time 
PCR reactions were performed using the 7500 Real-Time PCR System 
(Applied Biosystems).
ELISA. Retinas were dissected, flash frozen, and homogenized on ice in RIPA 
buffer containing a proteinase inhibitor cocktail (both from Sigma-Aldrich). 
The samples were centrifuged for 10 min at 8,000 g at 4°C. TGF-1 and IL-6 
were assayed in the supernatants using Quantikine kits (R&D Systems), accord-
ing to the manufacturer’s instructions. Cytokine levels were normalized to mil-
ligrams of protein, as quantified using the Pierce BCA Protein Assay kit (Thermo 
Fisher Scientific). The TGF-1 average for each group represents three inde-
pendent experiments, containing pooled samples, each comprised of two to six 
retinas. Single retinas were used for IL-6 ELISA (n = 4 in each group).
Statistical analysis. Data were analyzed using a Student’s t test to compare 
between  two  groups.  One-way  ANOVA  was  used  to  compare  several 
groups. Fisher’s LSD procedure was used for follow up pairwise comparison 
of groups after the null hypothesis had been rejected (F < 0.05). Results are 
presented as mean ± SE. In the graphs, y-axis error bars represent SE.
Online supplemental material. Fig. S1 shows the expression of TGF- 
by IB-4+ cells 6 h after glutamate intoxication. Fig. S2 depicts cntf mRNA 
expression at 6 h and 7 d after injury. Online supplemental material is avail-
able at http://www.jem.org/cgi/content/full/jem.20101202/DC1.
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Immunohistochemistry. After perfusion with PBS, eyes were removed, 
postfixed in 2.5% PFA for 24 h, transferred to 70% ethanol, and then embed-
ded into paraffin, as previously described (Shechter et al., 2007). For cytokine 
staining, eyes were postfixed in 2.5% PFA for 5 h and passed through a gradi-
ent of PFA-sucrose. Eyes were then embedded in Tissue-Tek O.C.T. com-
pound (Sakura) and sectioned by cryostat. The following antibodies were 
used: rabbit anti-GFP (1:100; MBL), rat anti-BrdU (1:100; AbD Serotec), 
mouse anti-Brn3a (1:50; Santa Cruz Biotechnology, Inc.), rabbit anti-Pax6 
(1:100; Covance), mouse anti–TGF-1, 2, 3 (1:150; R&D Systems), goat 
anti–IL-10 (1:20; R&D Systems), rabbit anti-IIIT (1:500; Covance), rabbit 
anti–PKC- (1:200; Santa Cruz Biotechnology, Inc.), and rabbit anti-Recoverin 
(1:1,000; Millipore). The M.O.M. immunodetection kit (Vector Laboratories) 
was used to localize mouse primary monoclonal antibodies. For activated   
myeloid cell labeling, FITC-conjugated Bandeiraea simplicifolia isolectin B4 
(IB-4; 1:50; Sigma-Aldrich) was added for 1 h to the secondary antibody solu-
tion. Secondary antibodies used included Cy2/Cy3-conjugated donkey anti–
mouse, –rat, –rabbit, or –goat antibodies (1:150-1:200, all from Jackson 
ImmunoResearch Laboratories, Inc.). Cy3-streptavidin was used for TGF-1, 
2, and 3 and IL-10 staining. The slides were exposed to Hoechst stain (1:2,000; 
Invitrogen) for 1 min. For microscopic analysis, a fluorescence microscope 
(E800; Nikon) or laser-scanning confocal microscope (Carl Zeiss, Inc.) was 
used. The fluorescence microscope was equipped with a digital camera (DXM 
1200F; Nikon) and with either a 20× NA 0.50 or 40× NA 0.75 objective lens 
(Plan Fluor; Nikon). The confocal microscope was equipped with LSM 510 
laser scanning (three lasers: Ar 488, HeNe 543, and HeNe 633) and with a 40× 
oil-immersion NA 1.3 Plan Neofluor objective lens. Recordings were made 
on postfixed tissues at 24°C using acquisition software (NIS-Elements, F3 
[Nikon] or LSM [Carl Zeiss, Inc.]). Images were cropped, merged, and opti-
mized using Photoshop 9.0 (Adobe) by making minor adjustments to contrast 
and were arranged using Canvas X (Deneba Software).
Isolation of the retina and flow cytometric analysis. Mice were anesthe-
tized, perfused intracardially with PBS, and their eyes were prepared for flow 
cytometric analysis. Retinas were removed by dissection and processed to   
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(W. Rasband, National Institutes of Health, Bethesda, MD).
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